Keyword: Pharmaceuticals

Markets & Companies

Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit

24.11.2017 - Of the remaining post-Brexit 27 member states of the European Union, Ireland looks likely to suffer the most economically, and also possibly politically, as a result of the UK’s...

Markets & Companies

The Italian Chemical Industry

24.11.2017 - Italy, given its relevant industrial manufacturing base, represents a large market for chemical products accounting for about €59 billion. With a turnover of about €52 billion in...

Markets & Companies

Green Chemistry and Smart Chemistry

24.11.2017 - As Austria’s second largest sector, the chemical industry is also among its most important. Spending on chemical research and innovation also surpasses that of other sectors. At...

Markets & Companies

The German Capital Region

24.11.2017 -

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500...

News

The Spanish Chemical Industry: a Strategic Sector on the Brink?

13.10.2017 - The Spanish economy has, since 2014, experienced the highest rate of growth among the main EU countries, thus presenting the best growth projections in terms of GDP, consumption...

Strategy & Management

Capitalizing On Precision Medicine

27.09.2017 - By applying a deeper understanding of diseases with richer patient data and advanced analytics, precision medicine can help physicians tailor medicines to the needs of individual...

Strategy & Management

Science that Enables Solutions for Clean Air, Improved Health and Sustainable Use of Resources

27.09.2017 - 2017 marks the 200th anniversary of UK specialty chemical and technology group Johnson Matthey which – back in 1817 – began as assayers, testing the purity of precious metals. In...

News

Bayer and J&J Win Second Xarelto Trial

15.06.2017 - A federal court in New Orleans, Louisiana, has cleared manufacturer Bayer and its US marketing partner Johnson & Johnson of liability in the second trial of what is expected to be...